Immune checkpoint molecules on T cells and their ligands on cancer cells, such as programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) prevent T cell activation when bound to each other. This evidence concerns the gene PDCD1 and cancer.